Armando Orlandi

Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025

Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, posted on X:

“Cowabunga! Riding Breast Cancer’s Biggest Data’s Wave from ASCO25
Racial disparities persist with HER2+ ADCs! Asian patients: 89.5% vs Black patients: 80.9% 5-year survival. 83.7% overall 5-year survival impressive, but equity gaps need addressing!”

Armando Orlandi: Racial Disparities in HER2+ Breast Cancer Outcomes at ASCO 2025

More posts featuring ASCO25.